This is supported by the finding that the high levels of HLA-G observed in the tumor microenvironment, induced by the differentiation of cancer cell lines, may increase the expression of PD-1 on T lymphocytes, which may be, in turn, suppressed by cancer cells expressing high levels of PD-L1 [69]. The gene discussed is HLA-G; the disease is cancer.